Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Novel treatment of onychomycosis using over-the-counter mentholated ointment: a clinical case series.

Derby R, Rohal P, Jackson C, Beutler A, Olsen C.

J Am Board Fam Med. 2011 Jan-Feb;24(1):69-74. doi: 10.3122/jabfm.2011.01.100124.

2.

A Novel Treatment for Onychomycosis in People Living With HIV Infection: Vicks VapoRub™ is Effective and Safe.

Snell M, Klebert M, Önen NF, Hubert S.

J Assoc Nurses AIDS Care. 2016 Jan-Feb;27(1):109-13. doi: 10.1016/j.jana.2015.10.004. Epub 2015 Oct 30. No abstract available.

PMID:
26585031
3.

Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream.

Syed TA, Qureshi ZA, Ali SM, Ahmad S, Ahmad SA.

Trop Med Int Health. 1999 Apr;4(4):284-7.

4.

A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.

Warshaw EM, Nelson D, Carver SM, Zielke GR, Webster N, Lederle FA, Fett DD.

Int J Dermatol. 2005 Sep;44(9):785-8. No abstract available.

PMID:
16135154
6.

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.

Gupta AK, Fleckman P, Baran R.

J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S70-80.

PMID:
11051136
7.
8.

Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.

Nakano N, Hiruma M, Shiraki Y, Chen X, Porgpermdee S, Ikeda S.

J Dermatol. 2006 Nov;33(11):753-8.

PMID:
17073989
9.
10.

Onychomycosis: rationalization of topical treatment.

Shemer A, Trau H, Davidovici B, Amichai B, Grunwald MH.

Isr Med Assoc J. 2008 Jun;10(6):415-6.

11.

Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.

Syed TA, Ahmadpour OA, Ahmad SA, Shamsi S.

J Dermatol. 1998 Oct;25(10):648-52.

PMID:
9830263
12.

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.

Sigurgeirsson B, Olafsson JH, Steinsson JB, Paul C, Billstein S, Evans EG.

Arch Dermatol. 2002 Mar;138(3):353-7.

PMID:
11902986
13.
14.

Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.

Smith EB, Stein LF, Fivenson DP, Atillasoy ES.

Int J Dermatol. 2000 Nov;39(11):861-4.

PMID:
11123452
15.

Prognostic factors for cure following treatment of onychomycosis.

Sigurgeirsson B.

J Eur Acad Dermatol Venereol. 2010 Jun;24(6):679-84. doi: 10.1111/j.1468-3083.2009.03487.x. Epub 2009 Nov 19.

PMID:
19929941
16.

Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.

Aman S, Akbar TM, Hussain I, Jahangir M, Haroon TS.

J Coll Physicians Surg Pak. 2003 Nov;13(11):618-20.

PMID:
14700485
17.

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.

Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB.

J Am Acad Dermatol. 1998 Jun;38(6 Pt 2):S77-86.

PMID:
9631989
18.

Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial.

Sotiriou E, Koussidou-Eremonti T, Chaidemenos G, Apalla Z, Ioannides D.

Acta Derm Venereol. 2010 Mar;90(2):216-7. doi: 10.2340/00015555-0811. No abstract available.

19.

Intermittent pulse therapy with itraconazole for onychomycosis. Experience in Hong Kong Chinese.

Tang WY, Chong LY, Leung CY, Ho HH, Wong TW.

Mycoses. 2000;43(1-2):35-9.

PMID:
10838844
20.

Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.

Piraccini BM, Sisti A, Tosti A.

J Am Acad Dermatol. 2010 Mar;62(3):411-4. doi: 10.1016/j.jaad.2009.04.062.

PMID:
20159308

Supplemental Content

Support Center